ESC 365 - The PARTHENOPE Trial: Personalized vs Standard DAPT after PCI

ESC2025 Premium Access

The PARTHENOPE Trial: Personalized vs Standard DAPT after PCI

Session: Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances

Topic: Pharmacotherapy

Speaker: Associate Professor R. Piccolo (Naples, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Raffaele Piccolo

University of Naples Federico II, Naples (Italy)

1 presentation

0 follower

3 more presentations in this session

TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI

Speaker: Professor A. Hakeem (Karachi, PK)

Device success in the Multivessel TALENT trial

Speaker: Professor P. Serruys (Galway, IE)

APERITIF trial

Speaker: Professor E. Puymirat (Paris, FR)

Access the full session

Late-Breaking Clinical Trials: antithrombotic strategies and PCI advances

Speakers: Associate Professor R. Piccolo, Professor A. Hakeem, Professor P. Serruys, Professor E. Puymirat

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources